🔴 10x Genomics is trading 4% down in pre-market as global risk-off sentiment pressures growth stocks

10x Genomics is trading 4.16% down now at $55.58 in pre-market amid broad risk-off sentiment affecting growth-oriented stocks.

• No clear company-specific overnight catalyst emerged; recent searches found only prior earnings coverage and an August 17 insider-sale report, neither directly explaining the decline.
• The Nasdaq Composite is down 1.10%; geopolitical tensions, rising oil prices, and higher bond yields are pressuring growth-oriented stocks.
• Confidence is medium because company-specific coverage is limited.